US Patent Issued to IMMUNOCORE on March 31 for "CD3-specific binding molecules" (British Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,152, issued on March 31, was assigned to IMMUNOCORE Ltd. (Abingdon, Great Britain).

"CD3-specific binding molecules" was invented by Martina Canestraro (Abingdon, Great Britain), Nele Dieckmann (Abingdon, Great Britain), Stephen Harper (Abingdon, Great Britain), Peter Benedict Kirk (Abingdon, Great Britain), Rachel Mulvaney (Abingdon, Great Britain), Ronan O'Dwyer (Abingdon, Great Britain) and Ian Butler Robertson (Abingdon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to specific binding molecules which bind to CD3, particularly antibodies and fragments thereof, with improved properties."

The patent w...